Download

DENVER--(BUSINESS WIRE)--Matrix
Analytics is the recipient of a grant from the Colorado Office of
Economic Development and International Trade. The grant will be used to
obtain regulatory approval for the radiomic and prediction modules that
will integrate into LungDirect,
a software application currently used to optimize pulmonary nodule and
lung cancer patient care.

Dr. Akrum Alzubaidi, an Interventional Pulmonologist at National Jewish
Health in Denver, Colorado, and Founder of Matrix Analytics says,
“Focused efforts like ours in artificial intelligence and deep learning
are needed to bring true sea change. We are the first to implement a
platform that will enable modification of the pre-test probability, not
just on pulmonary nodules, but on any disease state. This is key for
meaningful machine learning. Pairing this grant with the best minds in
medicine and business, while leveraging the power of Amazon AWS deep
learning instances, the possibilities become endless.”

LungDirect is a proprietary software suite developed to improve
disjointed care for pulmonary nodule patients. Electronic Medical Record
systems are not equipped to manage nodule care coordination, and
LungDirect offers an innovative way for providers to manage both lung
cancer screening patients and other at-risk pulmonary nodule patients.

Matrix Analytics President, Christine Spraker, adds, “We are excited
about what this grant will do for patients with pulmonary nodules. We
see a future where the platform in which LungDirect is built upon
revolutionizes the way healthcare is delivered. This is just the first
step.”

About Matrix Analytics: Matrix Analytics is a collection of
clinical and business experts aligned in the belief that conquering
illness and disease requires data, creativity, and an unrelenting focus
on Always Learning. First in our sights: Lung Cancer. Despite recent
clinical advancements and available technology, an integrated solution
to drive the consistent and efficient detection, diagnosis, and
treatment of pulmonary nodules and lung cancer does not exist.
LungDirect is the first line of defense in the fight. LungDirect
registers incidental pulmonary nodules and screening patients to a
dashboard and makes a user aware of these patients so they can be
followed and treated according to standard clinical care guidelines.
Pulmonary nodule management has never been easier!